Article

Winds of Change: An Evidence-Based Approach

Interest in the concept of evidence-based medicine is spreading throughout all medical disciplines, and it is making in-roads in ophthalmology as well, according to panelists in an evening CME symposium held Friday at the Astor Crowne Plaza.

New Orleans-Interest in the concept of evidence-based medicine is spreading throughout all medical disciplines, and it is making in-roads in ophthalmology as well, according to panelists in an evening CME symposium held Friday at the Astor Crowne Plaza. Evidence-based medicine is the integration of best research evidence with clinical expertise and patient values.

Stephen C. Pflugfelder, MD, Baylor College of Medicine, Houston, moderated the program, which featured discussions on efficacy and patient perspectives in glaucoma management. Panelists also discussed new developments regarding specific conditions, such as dysfunctional tear syndrome and chronic dry eye disease, as well as evidence supporting the fourth-generation fluoroquinolones. The program closed with a presentation on retinal perspectives on cystoid macular edema diagnosis, treatment, and prevention.

Presenters included Dimitri T. Azar, MD, Harvard Medical School and Massachusetts Eye and Ear Infirmary; Jeffrey S. Heier, MD, Tufts University School of Medicine and Harvard University Medical School, Boston; Francis S. Mah, MD, University of Pittsburgh School of Medicine; Robert J. Noecker, MD, MBA, University of Pittsburgh School of Medicine; Randall J. Olson, MD, University of Utah, Salt Lake City; and Steven T. Simmons, MD, Glaucoma Consultants of the Capitol Region, Albany, New York.

The program was jointly sponsored by Ophthalmology Times and the New York Eye and Ear Infirmary and supported by an unrestricted educational grant from Allergan.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
© 2025 MJH Life Sciences

All rights reserved.